Borna disease virus (BDV) surface glycoprotein (GP) (p56) has a predicted molecular mass of 56 kDa. Due to extensive posttranslational glycosylation the protein migrates as a polypeptide of 84 kDa (gp84). The processing of gp84 by the cellular protease furin generates gp43, which corresponds to the C-terminal part of gp84. Both gp84 and gp43 have been implicated in viral entry involving receptor-mediated endocytosis and pH-dependent fusion. We have investigated the domains of BDV p56 involved in virus entry. For this, we used a pseudotype approach based on a recently developed recombinant vesicular stomatitis virus (VSV) in which the gene for green fluorescent protein was substituted for the VSV G protein gene (VSV⌬G*). Complementation of VSV⌬G* with BDV p56 resulted in infectious VSV⌬G* pseudotypes that contained both BDV gp84 and gp43. BDV-VSV chimeric GPs that contained the N-terminal 244 amino acids of BDV p56 and amino acids 421 to 511 of VSV G protein were efficiently incorporated into VSV⌬G* particles, and the resulting pseudotype virions were neutralized by BDV-specific antiserum. These findings indicate that the N-terminal part of BDV p56 is sufficient for receptor recognition and virus entry.Borna disease virus (BDV) is the causal agent of Borna disease, a frequently fatal meningoencephalitis affecting mainly horses and sheep in certain regions of central Europe. Experimentally, BDV can infect a remarkably large number of vertebrate species. The infection is characterized by a variable period of incubation with diverse clinical and pathological manifestations (15,25,37), and behavioral disturbances are a hallmark of BDV infection. Serological and molecular-epidemiology data indicate that the host range, geographic distribution, and prevalence of BDV may be much broader than previously thought. There is also evidence that BDV can infect humans and might be associated with some neuropsychiatric disorders (1,2,9,10,18,24,28,30,38,41). However, the prevalence and possible clinical significance of BDV in humans remain controversial (46).BDV is an enveloped, nonsegmented, negative-strand (NNS) RNA virus (8,43). BDV has the smallest genome size, 8.9 kb, among known mononegaviruses. Unlike what is found for all other NNS RNA animal viruses, transcription and replication of the BDV genome take place in the nucleus (3-5). BDV uses RNA splicing for the regulation of its genome expression, which is also unique among known mononegaviruses. Based on its unique biological and molecular-genetics features, BDV is now considered to be the prototypic member of a new family, Bornaviridae, within the order Mononegavirales.The BDV genome contains six major open reading frames (ORFs). The product of BDV ORF IV is the counterpart of the type I surface glycoproteins (GPs) found in other members of the Mononegavirales. BDV GP (p56) has a predicted molecular mass of 56 kDa, but due to extensive N glycosylation the protein migrates with an apparent molecular mass of 84 kDa (gp84). BDV GP is processed posttranslationally by the su...